1. Home
  2. HCKT vs LCTX Comparison

HCKT vs LCTX Comparison

Compare HCKT & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hackett Group Inc (The).

HCKT

Hackett Group Inc (The).

HOLD

Current Price

$11.16

Market Cap

285.1M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

301.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCKT
LCTX
Founded
1991
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
285.1M
301.7M
IPO Year
1998
1996

Fundamental Metrics

Financial Performance
Metric
HCKT
LCTX
Price
$11.16
$1.07
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$17.00
$6.25
AVG Volume (30 Days)
387.2K
932.4K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
3.67%
N/A
EPS Growth
N/A
N/A
EPS
0.34
N/A
Revenue
$285,862,000.00
$14,556,000.00
Revenue This Year
$2.55
$109.40
Revenue Next Year
$5.07
N/A
P/E Ratio
$32.82
N/A
Revenue Growth
N/A
53.24
52 Week Low
$9.16
$1.00
52 Week High
$21.33
$2.09

Technical Indicators

Market Signals
Indicator
HCKT
LCTX
Relative Strength Index (RSI) 54.03 39.65
Support Level $9.61 $1.00
Resistance Level $11.89 $1.18
Average True Range (ATR) 0.59 0.06
MACD 0.07 0.00
Stochastic Oscillator 71.00 36.11

Price Performance

Historical Comparison
HCKT
LCTX

About HCKT Hackett Group Inc (The).

The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: